Beth Taylor Sells 4,370 Shares of Inotiv, Inc. (NASDAQ:NOTV) Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of Inotiv stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $4.01, for a total transaction of $17,523.70. Following the transaction, the chief financial officer now directly owns 108,368 shares in the company, valued at approximately $434,555.68. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The shares were sold at an average price of $4.46, for a total transaction of $9,160.84.

Inotiv Trading Up 9.0 %

NASDAQ NOTV opened at $4.25 on Friday. The company has a debt-to-equity ratio of 2.31, a current ratio of 1.57 and a quick ratio of 1.28. Inotiv, Inc. has a 1 year low of $1.23 and a 1 year high of $11.42. The company has a fifty day moving average of $4.36 and a 200 day moving average of $2.94. The company has a market capitalization of $143.31 million, a PE ratio of -0.92 and a beta of 3.58.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%. Research analysts forecast that Inotiv, Inc. will post -0.79 earnings per share for the current year.

Institutional Trading of Inotiv

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Two Sigma Advisers LP grew its position in Inotiv by 31.6% in the 4th quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock valued at $93,000 after acquiring an additional 5,400 shares in the last quarter. Two Sigma Investments LP increased its holdings in shares of Inotiv by 67.8% in the 4th quarter. Two Sigma Investments LP now owns 71,689 shares of the company’s stock valued at $297,000 after acquiring an additional 28,965 shares during the last quarter. Mink Brook Asset Management LLC acquired a new position in shares of Inotiv in the 4th quarter valued at $223,000. Millennium Management LLC lifted its position in Inotiv by 553.7% in the fourth quarter. Millennium Management LLC now owns 287,899 shares of the company’s stock valued at $1,192,000 after acquiring an additional 243,860 shares during the last quarter. Finally, Cubist Systematic Strategies LLC grew its holdings in shares of Inotiv by 500.0% during the fourth quarter. Cubist Systematic Strategies LLC now owns 83,923 shares of the company’s stock worth $347,000 after buying an additional 69,936 shares during the last quarter. 18.17% of the stock is currently owned by hedge funds and other institutional investors.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.